Kinled Holding

Kinled Holding hold direct investments in over 125 innovative businesses in the Finance, Medical, and Technology sectors. In life sciences, we have a laser-focus on innovation in the biomedical technology, medical devices, robotics, neuromodulation, and digital healthcare services sectors, which represents over 50% of our portfolio. In digital technologies, we invest in SaaS-enabled networks and marketplaces, with a strong emphasis on digital heath, where technology can democratize markets and provide consumers with greater choice of services, representing 25% of our portfolio. In fintech, we invest in companies that use technology to challenge the traditional established institutions by providing superior service in embedded payment platforms, insurance, real estate, lending and banking, which represents 25% of our portfolio. Kinled is also a Founding Partner/Director/Limited Partner in ten independent funds. This includes four dedicated Life Science investment companies managed from Vienna and Zurich, with combined Assets under Management of €300M; and six Digital Technology Funds based in Vienna, Zurich, London/Copenhagen, Prague/Bratislava, and Helsinki with combined Assets under Management of €225M.